Cart
sales@molnova.com
ARRY380
CAS No. 937265-83-3
ARRY380( ARRY-380 analog | ONT380 analog | ONT 380 analog | ONT-380 analog )
Catalog No. M16714 CAS No. 937265-83-3
ARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 84 | In Stock |
|
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 106 | In Stock |
|
| 25MG | 180 | In Stock |
|
| 50MG | 261 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameARRY380
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM.
-
DescriptionARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR.
-
In Vitro——
-
In Vivo——
-
SynonymsARRY-380 analog | ONT380 analog | ONT 380 analog | ONT-380 analog
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR| HER2| p95-HER2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number937265-83-3
-
Formula Weight569.63
-
Molecular FormulaC29H27N7O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO: > 10mM
-
SMILESCC1=C(OC2=CC3=NC=NN3C=C2)C=CC(NC2=NC=NC3=C2C=C(C=C3)C2=CC=C(CNCCS(C)(=O)=O)O2)=C1
-
Chemical Name6-[5-[[[2-(Methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Madala SK, et al. Am J Respir Cell Mol Biol. 2012 Mar;46(3):380-8.
molnova catalog
related products
-
Tyrphostin A25
Tyrphostin A25 (Tyrphostin AG 82) is a specific EGFR tyrosine kinase inhibitor and GPR35 agonist with an IC50 value of 0.94 μM for GPR35 and an EC50 value of 5.3 μM for GPR35.
-
E4CPG
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.
-
Allitinib
Allitinib (AST-1306) has anti-cancer activity，and it is an irreversible EGFR and ErbB2 inhibitor with IC50s of 0.5 and 3 nM, respectively.
